3例自身免疫性血友病样凝血因子缺陷症患者ⅩⅢ诊断流程的初步建立及文献回顾

doi:10.16150/j.1671-2870.2018.06.006

诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (06): 650-657.doi: 10.16150/j.1671-2870.2018.06.006

3例自身免疫性血友病样凝血因子缺陷症患者ⅩⅢ诊断流程的初步建立及文献回顾

马思雨^a, 梁茜^b, 陈昌明^b, 王学锋^b, 丁秋兰^b

上海交通大学医学院附属瑞金医院 a. 医学基因组国家重点实验室上海血液学研究所; b. 检验科, 上海 200025

收稿日期:2018-10-15 出版日期:2018-12-25 发布日期:2018-12-25
通讯作者: 丁秋兰 E-mail: qiulan_ding@126.com
基金资助:
国家自然科学基金面上项目（81770135）

Preliminary establishment of a flowchart for diagnosis, treatment of patients with autoimmune hemophilia-like coagulation factorⅩⅢ deficiency, review of literature

MA Siyu^a, LIANG Qian^b, CHEN Changming^b, WANG Xuefeng^b, DING Qiulan^b

a. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology; b. Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received:2018-10-15 Online:2018-12-25 Published:2018-12-25

摘要/Abstract

摘要： 目的：对3例疑似自身免疫性血友病样凝血因子ⅩⅢ缺陷症（autoimmune haemorrhaphilia factor ⅩⅢ, AHⅩⅢ）患者进行检测, 明确其临床诊断、治疗及随访资料, 建立完整的AHⅩⅢ实验诊断流程。方法：收集3例AHⅩⅢ患者的临床信息, 通过氨释放法检测其凝血因子ⅩⅢ（factor ⅩⅢ, F ⅩⅢ）活性, 酶联免疫吸附试验（enzyme linked immunosorbent assay, ELISA）法检测F ⅩⅢ-A抗原（FⅩⅢ-A:Ag）、FⅩⅢ-B:Ag。抗FⅩⅢ抗体检测包括混合实验检测抗FⅩⅢ中和抗体的存在、Bethesda法测定抗FⅩⅢ抗体滴度、ELISA法检测抗FⅩⅢ-A亚基抗体等。结果：3例患者的尿素法FⅩⅢ定性试验均为阳性, FⅩⅢ活性<5%, FⅩⅢ-A:Ag<3%, FⅩⅢ-B:Ag分别为65.40%、116.28%、138.81%。3例患者混合实验均为阳性, Bethesda法测定抗FⅩⅢ中和抗体滴度分别为1.83 BU、1.67 BU、1.75 BU, 免疫法检测结果提示均存在抗FⅩⅢ-A亚基抗体。结论：建立了完整的ⅩⅢ的诊断流程, 并回顾了其诊断、治疗及预后相关文献。经诊断, 本研究3例患者均为低滴度抗FⅩⅢ-A亚基抗体导致的AHⅩⅢ。

关键词: 自身免疫性血友病样凝血因子ⅩⅢ缺陷症;, 诊断, 治疗

Abstract: Objective: To test and diagnose definitely three patients with suspected autoimmune hemophilia-like coagulation factor ⅩⅢ (AH ⅩⅢ) deficiency and establish a flowchart for the laboratory diagnosis of AH ⅩⅢ deficiency. Methods: The clinical data of these 3 patients were recorded. FⅩⅢ: Act was detected by ammonia release assay. F ⅩⅢ-A: Ag and F ⅩⅢ-B: Ag were assayed by ELISA. Laboratory mixing tests and Bethesda method were used to detect anti-F ⅩⅢ neutralizing antibody, and ELISA was used to detect the autoantibodies against F ⅩⅢ-A. Results: For the 3 patients, positive results were shown by ammonia release assay. FⅩⅢ: Act <5%, F ⅩⅢ-A: Ag <3% and FⅩⅢ-B: Ag were 65.40%, 116.28% and 138.81%, respectively. Laboratory mixing tests were positive in all the 3 patients, and Bethesda method revealed that the neutralizing antibody were 1.83 BU, 1.67 BU and 1.75 BU, respectively. Autoantibodies against F ⅩⅢ-A were detected by immunological assay in all the 3 patients. Conclusions: A flowchart for laboratory diagnosis of AH ⅩⅢ deficiency is established. All the 3 patients were diagnosed as AH ⅩⅢ deficiency caused by low titer autoantibodies against F ⅩⅢ-A. Relevant literature about the diagnosis, treatment and prognosis of AH ⅩⅢ deficiency is reviewed.

Key words: Autoimmune hemophilia-like coagulation factor ⅩⅢ, Diagnosis, Treatment

中图分类号:

R730.43

马思雨, 梁茜, 陈昌明, 王学锋, 丁秋兰. 3例自身免疫性血友病样凝血因子缺陷症患者ⅩⅢ诊断流程的初步建立及文献回顾[J]. 诊断学理论与实践, 2018, 17(06): 650-657.

MA Siyu, LIANG Qian, CHEN Changming, WANG Xuefeng, DING Qiulan. Preliminary establishment of a flowchart for diagnosis, treatment of patients with autoimmune hemophilia-like coagulation factorⅩⅢ deficiency, review of literature[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 650-657.

参考文献

[1] Dorgalaleh A, Rashidpanah J.Blood coagulation factor ⅩⅢ and factor ⅩⅢ deficiency[J]. Blood Rev,2016,30(6):461-475.
[2] Levy JH, Greenberg C.Biology of Factor ⅩⅢ and clinical manifestations of Factor ⅩⅢ deficiency[J]. Transfusion,2013,53(5):1120-1131.
[3] Schroeder V, Kohler HP.Factor ⅩⅢ: Structure and Function[J]. Semin Thromb Hemost,2016,42(4):422-428.
[4] Komáromi I, Bagoly Z, Muszbek L, et al.Factor ⅩⅢ: novel structural and functional aspects[J]. J Thromb Haemost,2011,9(1):9-20.
[5] Dickneite G, Herwald H, Korte W, et al.Coagulation factor ⅩⅢ: a multifunctional transglutaminase with clinical potential in a range of conditions[J]. Thromb Haemost,2015,113(4):686-697.
[6] Muszbek L, Bereczky Z, Bagoly Z, et al.Factor ⅩⅢ: a coa-gulation factor with multiple plasmatic and cellular functions[J]. Physiol Rev,2011,91(3):931-972.
[7] Schroeder V, Kohler HP.New developments in the area of factor ⅩⅢ[J]. J Thromb Haemost,2013,11(2):234-244.
[8] Byrnes JR, Wolberg AS.Newly-Recognized Roles of Factor ⅩⅢ in Thrombosis[J]. Semin Thromb Hemost,2016,42(4):445-454.
[9] Kohler HP, Ichinose A, Seitz R, et al.Diagnosis and classification of factor ⅩⅢ deficiencies[J]. J Thromb Haemost,2011,9(7):1404-1406.
[10] Ichinose A, Japanese Collaborative Research Group (JCRG) on AH13 Hemorrhagic Acquired Coagulopathies.Inhibitors of Factor ⅩⅢ/13 in older patients[J]. Semin Thromb Hemost,2014,40(6):704-711.
[11] Ichinose A,Japanese Collaborative Research Group on AH13. Autoimmune acquired factor ⅩⅢ deficiency due to anti-factor ⅩⅢ/13 antibodies: A summary of 93 patients[J]. Blood Rev,2017,31(1):37-45.
[12] Muszbek L, Pénzes K, Katona é.Auto- and alloantibodies against factor ⅩⅢ: laboratory diagnosis and clinical consequences[J]. J Thromb Haemost,2018,16(5):822-832.
[13] Tone KJ, James TE, Fergusson DA, et al.Acquired Factor ⅩⅢ Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series[J]. Transfus Med Rev,2016,30(3):123-131.
[14] Souri M, Osaki T, Ichinose A, et al.Anti-factor ⅩⅢ A subunit (F ⅩⅢ-A) autoantibodies block FⅩⅢ-A2 B2 assembly and steal F ⅩⅢ-A from native F ⅩⅢ-A2 B2[J]. J Thromb Haemost,2015,13(5):802-814.
[15] Ajzner E, Schlammadinger A, Kerényi A, et al.Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor ⅩⅢ: a novel form of acquired factor ⅩⅢ deficiency[J]. Blood, 2009,113(3):723-725.
[16] Boehlen F, Casini A, Chizzolini C, et al.Acquired factor ⅩⅢ deficiency: a therapeutic challenge[J]. Thromb Haem-ost,2013,109(3):479-487.
[17] Muszbek L, Katona é.Diagnosis and Management of Congenital and Acquired F ⅩⅢ Deficiencies[J]. Semin Thromb Hemost,2016,42(4):429-439.
[18] Katona é, Pénzes K, Molnár é, et al.Measurement of factor ⅩⅢ activity in plasma[J]. Clin Chem Lab Med,2012, 50(7):1191-1202.
[19] Kessel R, Hu C, Shore-Lesserson L, et al.A child with acquired factor ⅩⅢ deficiency: case report and literature review[J]. Haemophilia, 2013,19(6):814-826.
[20] Osaki T, Sugiyama D, Magari Y, et al.Rapid immunochromatographic test for detection of anti-factor ⅩⅢ A subunit antibodies can diagnose 90% of cases with autoimmune haemorrhaphilia ⅩⅢ/13[J]. Thromb Haemost,2015,113(6):1347-1356.
[21] Franchini M, Mannucci PM.Acquired haemophilia A: a 2013 update[J]. Thromb Haemost,2013,110(6):1114-1120.
[22] Christiansen J, Kahn R, Schmidtchen A, et al.Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia[J]. Acta Derm Venereol,2015,95(2):227-228.
[23] Cohen JI.Cinical practice: Herpes zoster[J]. N Engl J Med,2013,369(3):255-263.
[24] de Jager T, Pericleous L, Kokot-Kierepa M, et al. The burden and management of F ⅩⅢ deficiency[J]. Haemophilia,2014,20(6):733-740.
[25] Inbal A, Oldenburg J, Carcao M, et al.Recombinant factor ⅩⅢ: a safe and novel treatment for congenital factor ⅩⅢ deficiency[J]. Blood, 2012,119(22):5111-5117.

3例自身免疫性血友病样凝血因子缺陷症患者ⅩⅢ诊断流程的初步建立及文献回顾

Preliminary establishment of a flowchart for diagnosis, treatment of patients with autoimmune hemophilia-like coagulation factorⅩⅢ deficiency, review of literature

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[3]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[4]	施霞, 马鑫, 王珍燕, 张晖, 刘少军. 32例人类免疫缺陷病毒感染合并慢性肾病患者的临床病理特征及随访结果分析[J]. 诊断学理论与实践, 2022, 21(04): 437-443.
[5]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[6]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[7]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[8]	李佳, 吕良敬. 靶向治疗时代议自身免疫病的感染挑战[J]. 诊断学理论与实践, 2022, 21(03): 299-303.
[9]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[10]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[11]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.
[12]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[13]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[14]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.
[15]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.